CA3112040C - Compositions et procedes de fabrication et d'utilisation de particules de type viral (vlp) - Google Patents

Compositions et procedes de fabrication et d'utilisation de particules de type viral (vlp)

Info

Publication number
CA3112040C
CA3112040C CA3112040A CA3112040A CA3112040C CA 3112040 C CA3112040 C CA 3112040C CA 3112040 A CA3112040 A CA 3112040A CA 3112040 A CA3112040 A CA 3112040A CA 3112040 C CA3112040 C CA 3112040C
Authority
CA
Canada
Prior art keywords
vaccine
rsv
mammalian subject
protein
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3112040A
Other languages
English (en)
Other versions
CA3112040A1 (fr
Inventor
Trudy Gilkerson Morrison
Original Assignee
University of Massachusetts Amherst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts Amherst filed Critical University of Massachusetts Amherst
Priority claimed from PCT/US2019/051864 external-priority patent/WO2020068540A1/fr
Publication of CA3112040A1 publication Critical patent/CA3112040A1/fr
Application granted granted Critical
Publication of CA3112040C publication Critical patent/CA3112040C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des compositions et des procédés d'utilisation de vaccins prophylactiques et/ou thérapeutiques pour immuniser des sujets, et la descendance de ujets femelles immunisés, contre le virus respiratoire syncytial (VRS). L'invention concerne également des compositions et des procédés pour produire des rendements accrus de particules de type viral de recombinaison (XzLP).
CA3112040A 2018-09-24 2019-09-19 Compositions et procedes de fabrication et d'utilisation de particules de type viral (vlp) Active CA3112040C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862735503P 2018-09-24 2018-09-24
US62/735,503 2018-09-24
US201962806526P 2019-02-15 2019-02-15
US62/806,526 2019-02-15
PCT/US2019/051864 WO2020068540A1 (fr) 2018-09-24 2019-09-19 Compositions et procédés de fabrication et d'utilisation de particules de type viral (vlp)

Publications (2)

Publication Number Publication Date
CA3112040A1 CA3112040A1 (fr) 2020-04-02
CA3112040C true CA3112040C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
CN111088283B (zh) mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗
US11111275B2 (en) Compositions and methods for making and using virus-like particles (VLPs)
KR100877019B1 (ko) 야생형 및 키메릭 인플루엔자 바이러스성입자(브이엘피)의 조립
US10751410B2 (en) Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods
CA2673373C (fr) Proteine f du virus respiratoire syncytial (rsv), et son utilisation
CN111603557A (zh) 一种包膜替换型病毒载体疫苗及其构建方法
US20110008838A1 (en) Chimeric varicella zoster virus virus-like particles
CN113881704A (zh) 一种包含新型冠状病毒双抗原靶标序列组合的重组新城疫病毒载体及相应疫苗株和疫苗
US20140134203A1 (en) Respiratory Syncytial Virus (RSV) Sequences For Protein Expression and Vaccines
CN114213548B (zh) 同时诱导抗多种病毒的免疫应答的方法
JP2000253876A (ja) センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
CN108602858A (zh) 嵌合rsv、免疫原性组合物以及使用方法
CN116063572B (zh) 一种同时表达bvdv e2蛋白和brsv f蛋白的融合蛋白及二联亚单位疫苗
JP2004517612A (ja) マーカーワクチンとしての、組み換えニューカッスル病ウイルス核タンパク質の突然変異体
KR20250088606A (ko) 호흡기 세포융합 바이러스 백신 및 이의 제조 방법과 용도
CN118440937B (zh) 新型的人合胞病毒RSV B mRNA疫苗
US12440552B2 (en) Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
CN115960180A (zh) 2019-nCoV S蛋白的突变体及其基因工程化的mRNA和疫苗组合物
CN113801206B (zh) 利用受体识别域诱导抗新冠病毒中和抗体的方法
CN117247463A (zh) 一种展示新冠病毒s蛋白的融合蛋白和重组病毒粒子及其应用
CN116024237B (zh) 一种用于预防裂谷热的mRNA疫苗及其制备方法
CN113832168A (zh) mRNA疫苗及其制备方法和应用
CN117357643B (zh) 一种用于预防呼吸道合胞病毒的疫苗及制备方法
US20110311587A1 (en) Fusogenic virus-like particles and uses thereof
CN119144620B (zh) 呼吸道合胞病毒mRNA疫苗及其制备方法和应用